Cohbar Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,198.50
10,291.50
8,686.40
8,452.50
22,182.80
Total Accounts Receivable
-
-
522.30
-
-
Other Current Assets
19.50
88.20
110.80
164.30
260.60
Total Current Assets
1,218.10
10,379.70
9,319.60
8,616.70
22,443.40
Net Property, Plant & Equipment
4.60
199.60
230.50
176.50
520.70
Intangible Assets
-
-
-
23.10
20.20
Other Assets
750.50
20.50
36.80
46.90
56.80
Total Assets
1,973.20
10,599.80
9,586.90
8,863.20
23,041.20
ST Debt & Current Portion LT Debt
-
-
205.20
-
Accounts Payable
290.10
209.70
103.30
492.00
Other Current Liabilities
408.70
373.00
580.40
752.30
Total Current Liabilities
698.80
582.70
888.90
1,244.30
Long-Term Debt
204.80
205.00
-
-
Total Liabilities
903.60
787.70
888.90
1,244.30
Common Equity (Total)
1,064.20
9,812.10
8,698.00
7,618.90
Total Shareholders' Equity
1,069.60
9,812.10
8,698.00
7,618.90
Total Equity
1,069.60
9,812.10
8,698.00
7,618.90
Liabilities & Shareholders' Equity
1,973.20
10,599.80
9,586.90
8,863.20
Preferred Stock (Carrying Value)
5.40
-
-
-

About Cohbar

View Profile
Address
1455 Adams Drive
Pasadena California 94025
United States
Employees -
Website http://www.cohbar.com
Updated 07/08/2019
CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.